Drug profile · INN
thiotepa
TEPADINA
thiotepa (TEPADINA) is a dna inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — thiotepa
- US status
- approved
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- INJECTION
- Patents
- 0
- Programs
- 11
- Data quality
- 0.89
Quick answer
thiotepa (TEPADINA) is a dna inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is thiotepa?
thiotepa (TEPADINA) is a dna inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for thiotepa?
TEPADINA is a marketed brand name for thiotepa. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of thiotepa?
thiotepa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.